Entrada Therapeutics
TRDA
TRDA
62 hedge funds and large institutions have $397M invested in Entrada Therapeutics in 2023 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 22 increasing their positions, 14 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
3% less capital invested
Capital invested by funds: $411M → $397M (-$14M)
Holders
62
Holding in Top 10
4
Calls
–
Puts
–
Top Buyers
| 1 | +$1.59M | |
| 2 | +$1.51M | |
| 3 | +$1.48M | |
| 4 |
Morgan Stanley
New York
|
+$1.17M |
| 5 |
Bank of New York Mellon
New York
|
+$726K |
Top Sellers
| 1 | -$5.08M | |
| 2 | -$703K | |
| 3 | -$221K | |
| 4 |
State of Wisconsin Investment Board
Madison,
Wisconsin
|
-$158K |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$66K |